Differentiated Thyroid Carcinoma,
Showing 1 - 25 of >10,000
Locally Advanced or Metastatic Radioiodine-Refractory
Recruiting
- Thyroid Neoplasms
- Anlotinib Hydrochloride Capsule
-
Beijing, Beijing, China
- +2 more
Aug 9, 2023
Quality of Life in Differentiated Thyroid Carcinoma Undergoing
Not yet recruiting
- Thyroid Cancer
- minimally invasive procedure
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hopsital
Sep 13, 2023
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride
Not yet recruiting
- Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
- Anlotinib Hydrochloride Capsule and Penpulimab
-
Beijing, Beijing, ChinaYansongLin
Sep 25, 2023
Prospective, Non-interventional, Post-authorization Safety Study
Active, not recruiting
- Thyroid Carcinoma
- Sorafenib (Nexavar, BAY43-9006)
-
Multiple Locations, Japan(unnamed)
Aug 18, 2022
Differentiated Thyroid Cancer Trial (Low iodine diet)
Not yet recruiting
- Differentiated Thyroid Cancer
- Low iodine diet
- (no location specified)
Oct 25, 2022
Thyroglobulin Point of Care Assay for Rapid Detection of
Recruiting
- Differentiated Thyroid Cancer
- Lymph Node Metastases
- Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
-
Ashkelon, Israel
- +2 more
Oct 25, 2022
Renal Tracer Elimination in Thyroid Cancer Patients Treated With
Completed
- Thyroid Carcinoma
-
Jena, Thüringen, GermanyUniversity Hospital Jena
Dec 15, 2022
Selenium Deficiency, Thyroid Cancer TNM Staging, Recurrence Trial in Jinan (Selenium Yeast, Placebo)
Not yet recruiting
- Selenium Deficiency
- +3 more
- Selenium Yeast
- Placebo
-
Jinan, Shandong, ChinaThe First affiliated hospital of Shandong First Medical Universi
Mar 11, 2022
DTC - Differentiated Thyroid Cancer Trial in Beijing (Anlotinib HCl)
Recruiting
- DTC - Differentiated Thyroid Cancer
- Anlotinib hydrochloride
-
Beijing, ChinaPeking Union Medical College Hospital
Jan 18, 2022
Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic
Active, not recruiting
- Columnar Cell Variant Thyroid Gland Papillary Carcinoma
- +25 more
- Laboratory Biomarker Analysis
- +3 more
-
Torrance, California
- +6 more
Jan 12, 2023
18F-TFB PET/CT Scan in Differentiated Thyroid Cancer
Recruiting
- Differentiated Thyroid Gland Carcinoma
- +2 more
- Computed Tomography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer Trial in Philadelphia (Cabozantinib)
Active, not recruiting
- Differentiated Thyroid Cancer (DTC)
- Poorly Differentiated Thyroid Cancer
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 7, 2021
BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,
Recruiting
- BRAF NP_004324.2:p.V600M
- +6 more
- Binimetinib
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Aug 17, 2022
Thyroid Carcinoma
Recruiting
- Differentiated Thyroid Carcinoma
- Medullary Thyroid Carcinoma
- Immunohistochemistry (IHC)
- +2 more
-
L'Hospitalet De Llobregat, Barcelona, Spain
- +11 more
Mar 22, 2022
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
Lymph Node Dissection, Lymph Node Metastases, Differentiated Thyroid Carcinoma Trial in Guangzhou (contralateral central lymph
Unknown status
- Lymph Node Dissection
- +2 more
- contralateral central lymph node dissection
-
Guangzhou, Guangdong, ChinaFifth Affiliated Hospital, Sun Yat-Sen University
Nov 22, 2020
Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer Trial in New York, Houston (AIC100 CAR T
Recruiting
- Anaplastic Thyroid Cancer
- Relapsed/Refractory Poorly Differentiated Thyroid Cancer
- AIC100 CAR T Cells
-
New York, New YorkWeill Cornell Medical College
Feb 14, 2022
TCM Syndrome Factors and TSH Changes of Thyroid Hormone
Not yet recruiting
- Differentiated Thyroid Carcinoma
- TCM Syndrome Type
- (no location specified)
Jun 15, 2021
Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma Trial in Atlanta
Terminated
- Differentiated Thyroid Gland Carcinoma
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 25, 2021
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)
Terminated
- Thyroid Cancer
- +5 more
- Lenvatinib
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 12, 2021
Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Thyroid Gland Anaplastic Carcinoma by AJCC V8
Suspended
- Metastatic Thyroid Gland Carcinoma
- +2 more
- Lenvatinib
- +2 more
-
Saint Petersburg, Russian FederationSaint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
May 13, 2021